Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells

Biochem Biophys Res Commun. 2013 Nov 15;441(2):405-10. doi: 10.1016/j.bbrc.2013.10.074. Epub 2013 Oct 23.

Abstract

Pigment epithelium-derived factor (PEDF) exerts atheroprotective effects both in cell culture and animal models through its anti-oxidative and anti-inflammatory properties. Caveolin-1 (Cav), a major protein component of caveolae in endothelial cells (ECs), plays a role in the progression of atherosclerosis. However, effects of PEDF on Cav-exposed ECs remain unknown. In this study, we examined whether and how PEDF could inhibit the Cav-induced inflammatory and thrombogenic reactions in human umbilical vein ECs (HUVECs). Surface plasmon resonance revealed that PEDF bound to Cav at the dissociation constant of 7.36×10(-7) M. Further, one of the major Cav-interacting proteins in human serum was identified as PEDF by peptide mass fingerprinting analysis using BIAcore 1000 combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Exogenously added Cav was taken up into the membrane fraction of HUVECs and dose-dependently increased monocyte chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1) and plasminogen activator inhibitor-1 (PAI-1) mRNA levels, all of which were blocked by the simultaneous treatment with 10nM PEDF. Small interfering RNAs directed against Cav decreased endogenous Cav levels and suppressed gene expression of MCP-1, VCAM-1 and PAI-1 in HUVECs. This study indicates that PEDF binds to Cav and could block the inflammatory and thrombogenic reactions in Cav-exposed HUVECs. Our present study suggests that atheroprotective effects of PEDF might be partly ascribed to its Cav-interacting properties.

Keywords: Caveolin-1; Endothelial cells; Inflammation; MALDI-TOF mass spectrometry; PEDF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / genetics
  • Atherosclerosis / metabolism*
  • Caveolin 1 / genetics
  • Caveolin 1 / metabolism*
  • Caveolin 1 / pharmacology
  • Chemokine CCL2 / genetics
  • Eye Proteins / genetics
  • Eye Proteins / metabolism*
  • Eye Proteins / pharmacology
  • Gene Expression / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Humans
  • Inflammation / genetics
  • Inflammation / metabolism*
  • Nerve Growth Factors / genetics
  • Nerve Growth Factors / metabolism*
  • Nerve Growth Factors / pharmacology
  • Plasminogen Activator Inhibitor 1 / genetics
  • RNA, Small Interfering / genetics
  • Serpins / genetics
  • Serpins / metabolism*
  • Serpins / pharmacology
  • Thrombosis / genetics
  • Thrombosis / metabolism
  • Vascular Cell Adhesion Molecule-1 / genetics

Substances

  • CAV1 protein, human
  • CCL2 protein, human
  • Caveolin 1
  • Chemokine CCL2
  • Eye Proteins
  • Nerve Growth Factors
  • Plasminogen Activator Inhibitor 1
  • RNA, Small Interfering
  • Serpins
  • Vascular Cell Adhesion Molecule-1
  • pigment epithelium-derived factor